Exponent, Inc.
- Jurisdiction
United States - LEI
529900NY3F5Q2NWPUZ42 - ISIN
US30214U1025 (EXPO )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Read full profile
Fundamentals
- Net revenue
€476.87M - Gross margin
60.2% - EBIT
€113.68M - EBIT margin
23.8% - Net income
€89.99M - Net margin
18.9%
Statement period: - (published )
Stock price
Dividends
- Last dividend amount
-
$0.30 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
55.9%
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Corrigan Catherine | President & CEO |
|
|
|
|
| Sala Joseph | Group Vice President |
|
|
|
|
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Lisa McClain | September 12, 2025 | $1.00K–$15.00K |
| Jefferson Shreve | June 22, 2025 | $15.00K–$50.00K |
| Jefferson Shreve | April 11, 2025 | $15.00K–$50.00K |
| Jefferson Shreve | March 9, 2025 | $15.00K–$50.00K |
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Buy |
Earnings Calls
Latest earnings call: April 25, 2024 (Q1 2024)